Arkolith/Insider Trading/STRO/Form 4

Vasquez Nicki

CHIEF PORT. STRAT & ALNCE OFCRSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed Jan 31, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 29, 2024Tax withholding(F)1K$4.99$5K14K
Jan 29, 2024Option exercise(M)3K—$015K
Jan 29, 2024Sell(S)12K$5.00$61K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 29, 2024Option exercise(M)3K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-002065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for SUTRO BIOPHARMA, INC.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp